中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Click chemistry-based synthesis and anticancer activity evaluation of novel C-14 1,2,3-triazole dehydroabietic acid hybrids

文献类型:期刊论文

作者Hou, Wei3; Luo, Zhi4; Zhang, Guanjun5; Cao, Danhui3; Li, Di3; Ruan, Haoqiang3; Ruan, Benfang Helen3; Su, Lin3; Xu, Hongtao1,2
刊名EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
出版日期2017-09-29
卷号138页码:1042-1052
关键词Terpenoids Dehydroabietic acid Cancer 1,2,3-triazole Synthesis Click chemistry Drug resistance
ISSN号0223-5234
DOI10.1016/j.ejmech.2017.07.049
文献子类Article
英文摘要A concise and efficient synthetic approach has been established to readily access a series of novel C-14 1,2,3-triazole-tethered dehydroabietic acid derivatives in moderate to high yields. In vitro anti proliferative activity evaluation indicated that most of the hybrids exhibited potent inhibitory activities in a variety of cancer cell lines with low micromolar to submicromolar IC50 values. Further studies demonstrated that some of these analogues such as 20, 21, and 24 were also effective against adriamycin-resistant MCF-7 clone at low concentrations in a dose-dependent manner. Notably, the most potent compound 24, which possesses a 3-(tert-butoxycarbonylamino)phenyl-substituted triazole moiety, not only exhibited obviously improved IC50 values ranging from 0.7 to 1.2 mu M against a panel of tested cancer cells, but also showed very weak cytotoxicity on normal cells. Preliminary mechanism studies indicated that compound 24 could induce apoptosis in MDA-MB-231 cells and was worth developing into a novel natural product-like anticancer lead by proper structure modification. (C) 2017 Elsevier Masson SAS. All rights reserved.
WOS关键词NATURAL-PRODUCTS ; DRUG DISCOVERY ; ABIETIC ACID ; IN-VITRO ; DERIVATIVES ; TRIPTOLIDE ; CANCER ; ANALOGS ; DESIGN ; RING
资助项目National Natural Science Foundation of NFSC, China[21502114] ; China Post-doctoral Science Foundation, China[2015M581677] ; Open Foundation of the State Key Laboratory of Drug Research, China[SIMM1601KF-05]
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000411297000080
出版者ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
源URL[http://119.78.100.183/handle/2S10ELR8/272476]  
专题药物化学研究室
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Su, Lin; Xu, Hongtao
作者单位1.ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China;
2.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
3.Zhejiang Univ Technol, Coll Pharmaceut Sci, Collaborat Innovat Ctr Yangtza River Delta Reg Gr, Hangzhou 310014, Zhejiang, Peoples R China;
4.Shanghai Evergene Biotech Co Ltd, Shanghai 201499, Peoples R China;
5.Tianjin Univ Sci & Technol, Coll Chem Engn & Mat Sci, Tianjin 300457, Peoples R China;
推荐引用方式
GB/T 7714
Hou, Wei,Luo, Zhi,Zhang, Guanjun,et al. Click chemistry-based synthesis and anticancer activity evaluation of novel C-14 1,2,3-triazole dehydroabietic acid hybrids[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2017,138:1042-1052.
APA Hou, Wei.,Luo, Zhi.,Zhang, Guanjun.,Cao, Danhui.,Li, Di.,...&Xu, Hongtao.(2017).Click chemistry-based synthesis and anticancer activity evaluation of novel C-14 1,2,3-triazole dehydroabietic acid hybrids.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,138,1042-1052.
MLA Hou, Wei,et al."Click chemistry-based synthesis and anticancer activity evaluation of novel C-14 1,2,3-triazole dehydroabietic acid hybrids".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 138(2017):1042-1052.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。